(Health-NewsWire.Net, September 17, 2018 ) This report studies Radiopharmaceuticals in Nuclear Medicine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Bracco Imaging S.P.A. Cambridge Isotope Laboratories, Inc. Cardinal Health, Inc. Covidien, Plc Eczacibasi-Monrol Fujifilm Holdings Corporation GE Healthcare (Subsidiary Of General Electric Company) IBA Group Isotec, Inc. (Sigma-Aldrich) Lantheus Medical Imaging, Inc. Nordion, Inc. Ntp Radioisotopes (Pty), Ltd. Siemens Healthcare (Subsidiary Of Siemens AG) Taiyo Nippon Sanso Corporation Urenco Limited Rotem Industries, Ltd., Inc. Australian Nuclear Association And Technology Organization (ANSTO) Board of Radiation And Isotope Technology (BRIT) Institute of Atomic Energy Polatom Radioisotope Centre Institute of Isotopes Co., Ltd. Institute Of Radioelement (IRE) Request a Sample Copy:https://www.worldwidemarketreports.com/sample/43462
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Diagnostic Radiopharmaceuticals Therapy Radiopharmaceuticals Enriched Stable Isotopes
By Application, the market can be split into Diagnostic Application Therapeutic Application Research Pharmaceutical Other
By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India
Table of Contents Global Radiopharmaceuticals in Nuclear Medicine Market Size, Status and Forecast 2022 1 Industry Overview of Radiopharmaceuticals in Nuclear Medicine 2 Global Radiopharmaceuticals in Nuclear Medicine Competition Analysis by Players 3 Company (Top Players) Profiles 3.1 Mobetize Corp. 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Radiopharmaceuticals in Nuclear Medicine Revenue (Value) (2013-2017) 3.1.5 Recent Developments 3.2 Remitly 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Radiopharmaceuticals in Nuclear Medicine Revenue (Value) (2013-2017) 3.2.5 Recent Developments 3.3 Regalii 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Radiopharmaceuticals in Nuclear Medicine Revenue (Value) (2013-2017) 3.3.5 Recent Developments 3.4 peerTransfer 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Radiopharmaceuticals in Nuclear Medicine Revenue (Value) (2013-2017) 3.4.5 Recent Developments 3.5 Currency Cloud 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Radiopharmaceuticals in Nuclear Medicine Revenue (Value) (2013-2017) 3.5.5 Recent Developments 3.6 Azimo 4 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type and Application (2013-2017) 5 United States Radiopharmaceuticals in Nuclear Medicine Development Status and Outlook 6 EU Radiopharmaceuticals in Nuclear Medicine Development Status and Outlook 7 Japan Radiopharmaceuticals in Nuclear Medicine Development Status and Outlook 8 China Radiopharmaceuticals in Nuclear Medicine Development Status and Outlook 9 India Radiopharmaceuticals in Nuclear Medicine Development Status and Outlook 10 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Development Status and Outlook 11 Market Forecast by Regions, Type and Application (2017-2022) 12 Radiopharmaceuticals in Nuclear Medicine Market Dynamics
Else place an Inquire before Purchase “Global Radiopharmaceuticals in Nuclear Medicine Market Size, Status and Forecast 2022: https://www.worldwidemarketreports.com/quiry/43462
Coherent Market Insights
Pareesh Phulkar
8087996871
pareesh@coherentmarketinsights.com
Source: EmailWire.Com
|